COVID-19 vaccines for sale on the underground for $250 to $1,200

Kaspersky researchers examined 15 different marketplaces on the Darknet and found advertisements for three major COVID vaccines: Pfizer/BioNTech, AstraZeneca, and Moderna. There were also sellers advertising unverified "COVID19" vaccines

  
COVID-19 vaccines for sale on the underground for $250 to $1,200

The entire globe is currently undergoing one of the largest and most complex vaccination campaigns in history, and, not surprisingly, scammers and sellers on the dark market have been eager to make a profit off the process.

Kaspersky researchers examined 15 different marketplaces on the Darknet and found advertisements for three major COVID vaccines: Pfizer/BioNTech, AstraZeneca, and Moderna. There were also sellers advertising unverified “COVID19” vaccines.

The majority of sellers came France, Germany, the UK, and the USA, and the prices per dose ranged from $250 to $1,200, with an average cost of about $500.  Communications are made via encrypted messaging apps like Wickr and Telegram, while payments are requested in the form of cryptocurrency, primarily bitcoin.

The majority of these underground sellers have made between 100-500 transactions, indicating that they’ve been completing sales but what exactly Darknet users are purchasing remains unclear. With the information available to Kaspersky experts, it’s impossible to tell how many of the vaccines doses being advertised online are actual doses (many medical facilities have found themselves with leftover doses) and how many advertisements are a scam.

Even if you did receive something in the mail, most likely what you would receive would not be an effective, valid dose. More importantly, obtaining such doses is illegal.

“You can find just about anything on the Darknet, so it’s not surprising sellers there would attempt to capitalize on the vaccination campaign. Over the past year, there have been a whole host of scams exploiting the COVID topic, and many of them have been successful. Right now, not only are people selling vaccine doses, but they’re also selling vaccination records—pieces of paper that can help you travel freely. It’s important for users to be cautious of any “deal” related to the pandemic, and, of course, it’s never a good idea to buy a vaccine off the Darknet,” comments Dmitry Galov, security expert at Kaspersky.

Learn more about these Darknet vaccines on Kdaily.

To stay safe from scammers at the time of COVID, Kaspersky experts recommend:

  • Never buy products—including vaccine doses—on the Darknet
  • If you see an advertisement for something related to COVID, look carefully at the URLs of the sites that you visit. If just one letter looks out of place, or if the usual .comhas been replaced with .com.tk or something along those lines, your gut should tell you it’s phishing. Never enter personal information on such a site.
  • Pay attention to grammar and layout on both the sites you visits and the emails you receive. If something smells phishy, it probably is

About KasperskyKaspersky is a global cybersecurity company founded in 1997. Kaspersky’s deep threat intelligence and security expertise is constantly transforming into innovative security solutions and services to protect businesses, critical infrastructure, governments and consumers around the globe. The company’s comprehensive security portfolio includes leading endpoint protection and a number of specialized security solutions and services to fight sophisticated and evolving digital threats. Over 400 million users are protected by Kaspersky technologies and we help 250,000 corporate clients protect what matters most to them. Learn more at www.kaspersky.com

For further information, please contact:
Sweta Fernandes, Account Executive, Golin, KasperskyTeam@golin.ae 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.


More From Press Releases